Remilk: Cow-Free Milk Hits Israeli Shelves
Remilk — Rehovot precision-fermentation dairy company. Founded 2019 by Aviv Wolff and Ori Cohavi. $150M+ raised, Hanaco-led. FDA, Israel, Singapore, Canada cleared. Launched "The New Milk" with Gad Dairies in Nov 2025. US 2026. Category's clearest surviving operator.
Remilk: Cow-Free Milk Hits Israeli Shelves
Remilk is the Israeli precision-fermentation dairy company that went commercial in November 2025 — launching cow-free bioidentical milk through Gad Dairies in Israeli cafes and hotels. Founded 2019, $150M+ raised, FDA-cleared. US launch planned 2026.
What Remilk Is
Remilk Ltd. is an Israeli food-tech company that produces dairy-identical milk proteins without cows. The technology is precision fermentation: insert the gene that codes for β-lactoglobulin — the primary protein in cow whey — into a yeast strain, ferment sugar as the feedstock, harvest the bioidentical protein. The output is real dairy protein, chemically indistinguishable from what cows produce, but without lactose, cholesterol, hormones, or antibiotic residues.
Headquartered in Rehovot. Founded June 2019.
The Founders
Aviv Wolff (CEO). Serial entrepreneur across business and social ventures before Remilk. Public voice of the company.
Ori Cohavi (CTO). PhD in Biochemistry. R&D career across Israeli biotech firms before co-founding. The technical half of the founding pair.
The Funding History
- Series A — December 2020. $11M, early institutional round.
- Series B — January 2022. $120M, led by Hanaco Ventures. Participants: Skyviews Life Science, Tencent, HFI, ICP, OurCrowd, CPT Capital, Target Global.
- Total to date: more than $150 million raised.
Regulatory Approvals
Regulatory clearance is the operational moat in precision fermentation. Remilk has stacked more of it than any Israeli competitor:
- United States — FDA "No Questions" letter (GRAS status) received 2023.
- Israel — Health Ministry approval 2022. First commercial launches November 2025.
- Singapore — approval received.
- Canada — approval received November 2025.
The four-jurisdiction clearance stack is what turns Remilk from a science story into a distribution story.
The Kalundborg Facility — The Ambition and the Reality
In April 2022, Remilk announced plans to build the world's largest precision-fermentation facility on 750,000 sq ft of newly acquired land in Kalundborg, Denmark — inside the Symbiosis industrial park where Novo Nordisk, Novozymes, and Chr. Hansen operate. Target output: annual dairy protein equivalent to that produced by 50,000 cows.
Since 2022 the precision-fermentation category has tightened. Capital compressed, few investors willing to underwrite billion-dollar fermentation plants absent proven demand. Remilk's public positioning has shifted: the strategy now runs through partnerships and agile production networks, with high-yield microbial strains carrying unit economics rather than owned mega-facility scale.
The 2025 Commercial Launch
November 2025 — "The New Milk." Remilk partnered with Gad Dairies, Israel's fourth-largest dairy company, to launch The New Milk range. Barista-style milk distributed to cafes, restaurants, and hotels first. Everyday and vanilla-flavored versions targeted for January retail launch. Yogurts and cream cheese in development.
Product composition. Remilk's recombinant β-lactoglobulin, combined with coconut and shea fats, calcium, vitamins D and E, natural flavors. Lactose-free. Approximately 75% less sugar than regular milk. Kosher pareve — a differentiator in a market where roughly two-thirds of consumers separate meat and dairy.
The next market. US launch planned for 2026. Partnership talks with large US CPG players reported by the founders.
Where Remilk Sits in the Category
Global precision-fermentation dairy peers include Perfect Day, Change Foods, Formo, Real Deal Milk, and — in Israel — Imagindairy. Two things separate Remilk inside that cohort:
- Approvals stack. Four jurisdictions cleared. Category leadership on the regulatory axis.
- Commercial launch executed. Most precision-fermentation companies have not put branded product on shelves. Remilk has — through the Gad Dairies partnership. Distribution beats deck.
Why It Matters
Israel as the precision-fermentation capital. Remilk plus Imagindairy plus Aleph Farms plus Redefine Meat gives Israel four category-defining alternative-protein operators — the anchor cluster of a category that most of the rest of the world is only building.
Kosher pareve as strategic wedge. Remilk's product is dairy-identical but pareve — a category that has never existed. The Israeli market segment for observant consumers is the first proof of demand for a globally unprecedented product category.
The Gad Dairies channel model. Rather than build its own consumer brand, Remilk partnered with an incumbent dairy operator. The template every follow-on precision-fermentation startup studies when it decides between DTC brand-building and B2B protein ingredient supply.
One-Line Summary
Remilk is the Israeli precision-fermentation dairy company that cleared four regulators, partnered with Gad Dairies, and launched cow-free bioidentical milk in Israeli cafes in November 2025 — the category's clearest surviving operator and the US 2026 launch to watch.
